tiprankstipranks
Trending News
More News >
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Australian Market

AFT Pharmaceuticals Ltd. (AFP) Price & Analysis

Compare
5 Followers

AFP Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

69.71%30.29%
69.71% Insiders
Mutual Funds
― Other Institutional Investors
30.29% Public Companies and
Individual Investors

AFP FAQ

What was AFT Pharmaceuticals Ltd.’s price range in the past 12 months?
AFT Pharmaceuticals Ltd. lowest share price was AU$2.10 and its highest was AU$3.90 in the past 12 months.
    What is AFT Pharmaceuticals Ltd.’s market cap?
    AFT Pharmaceuticals Ltd.’s market cap is AU$256.90M.
      When is AFT Pharmaceuticals Ltd.’s upcoming earnings report date?
      AFT Pharmaceuticals Ltd.’s upcoming earnings report date is Nov 20, 2025 which is in 162 days.
        How were AFT Pharmaceuticals Ltd.’s earnings last quarter?
        AFT Pharmaceuticals Ltd. released its earnings results on May 21, 2025. The company reported AU$0.121 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.121.
          Is AFT Pharmaceuticals Ltd. overvalued?
          According to Wall Street analysts AFT Pharmaceuticals Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does AFT Pharmaceuticals Ltd. pay dividends?
            AFT Pharmaceuticals Ltd. pays a Annually dividend of AU$0.014 which represents an annual dividend yield of 0.57%. See more information on AFT Pharmaceuticals Ltd. dividends here
              What is AFT Pharmaceuticals Ltd.’s EPS estimate?
              AFT Pharmaceuticals Ltd.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does AFT Pharmaceuticals Ltd. have?
              AFT Pharmaceuticals Ltd. has 104,866,260 shares outstanding.
                What happened to AFT Pharmaceuticals Ltd.’s price movement after its last earnings report?
                AFT Pharmaceuticals Ltd. reported an EPS of AU$0.121 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.961%.
                  Which hedge fund is a major shareholder of AFT Pharmaceuticals Ltd.?
                  Currently, no hedge funds are holding shares in AU:AFP

                  Company Description

                  AFT Pharmaceuticals Ltd.

                  AFT Pharmaceuticals Limited develops, licenses, distributes, and sells pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, eyecare, first aid, pain management, gastrointestinal, dermatology, and medicated vitamins. The company was incorporated in 1997 and is headquartered in Auckland, New Zealand.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Resonance Health Ltd
                  Noxopharm Ltd.
                  Althea Group Holdings Ltd.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis